Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.

Slides:



Advertisements
Similar presentations
CSO/NGO Consultations Report to IATI Signatories, Partner Countries and Steering Committee Paris, 4 July 2011.
Advertisements

Saul Walker Policy and Research Division, DFID Jordan 4 December, 2007 Medicines Transparency Alliance (MeTA)
Key challenges in mutual accountability - citizens and csos imperative in accountability Antonio Tujan Jr.
Good governance for water, sanitation and hygiene services
ENGAGING STRATEGICALLY WITH NON-STATE ACTORS IN NEW AID MODALITIES 7th July 2011 DEVCO-Europeaid – D2 civil Society.
Policies and Procedures for Civil Society Participation in GEF Programme and Projects presented by GEF NGO Network ECW.
Zambian Civil Society Organizations, TRIPS and Access to Medicines Zambia Civil Society Consultation Meeting 1 st October 2013 Daniel S. Libati, LLB (UNZA)
Presented to CSO workshops in Kabwe on 18 July 2014, Livingstone on 28 July 2014 and Lusaka on 27 August 2014.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Stockouts: The legal framework Sasha Stevenson 25 July 2013.
CSOs on the Road to Busan: Key Messages and Proposals March 2011.
Medicines Transparency Alliance Presented by Deirdre Dimancesco Department of Essential Medicines and Health Products, WHO at the Technical Briefing Seminar.
By Asayire Kapira.  The Water and Environmental Sanitation Network (WES Network) is a membership based Civil Society network that coordinates the work.
Supply Chains Management for Pharmacy
Towards an Integrity Standard in the Pharmaceutical Industry IACC Conference, May 27, 2003 Seoul, Korea Dr. Jillian Clare Cohen Assistant Professor, Leslie.
PRESENTATION TO THE MOLE CONFERENCE, CHANCES HOTEL, 15 JULY 2009 YIGA BAKER M ANEW REGIONAL COORDINATOR EASTERN AFRICA.
OPTIONS AND REQUIREMENTS FOR ENGAGEMENT OF CIVIL SOCIETY IN GEF PROJECTS AND PROGRAMMES presented by Faizal Parish Regional/Central Focal Point GEF NGO.
Pharmaceutical System Strengthening : Bangladesh Perspective Aktari Mamtaz Joint Secretary Ministry of Health and Family welfare (MOHFW), Bangladesh.
FORMATION OF THE GHANA MeTA CIVIL SOCIETY NETWORK : AN OVERVIEW 1 Allotey. C; 2 Ahiabu. R.K.A; 3 Ntoso. R.Y; 4 Azumah. S.K; 5 Andoh.I 1,5. Health Access.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
Participatory Audit and Planning (PAP) Process A tool for monitoring and ensuring “Decentralized planning’’ in utilization of Hospital Management Committee.
AIM 2030 Access to Innovative Medicines Draft concept for a new World Bank-led multi-stakeholder initiative August 2014, Andreas Seiter.
Establishing Research and Evaluation Network on Child Issues in Indonesia Nuning Akhmadi Indonesia Research and Evaluation Network Manila, 7 – 8 November.
MeTA Jordan Executive Summary Baseline data is an important source for policy makers to diagnose the pharmaceutical and health sector situation in order.
A Global Transparency Program for the Construction Sector Christiaan Poortman Chairman, CoST International Advisory Group 7 October, 2010.
Medicines Transparency Alliance13/09/ MeTA Uganda Country Overview Public Sector Private Sector Civil Society.
Wilbert Bannenberg SARPAM
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Medicines Transparency Alliance03/10/ MeTA Zambia Violet Kabwe MeTA Zambia Consultant.
PRACTICAL GUIDE FOR THE IMPLEMENTATION OF THE AU ROADMAP FOR SHARED RESPONSIBILITY AND GLOBAL SOLIDARITY FOR AIDS, TB AND MALARIA SABELO MBOKAZI -AUC 8.
Case development for a fund supporting CSOs active in national health policies Presentation to the IHP+ Steering Committee.
3 August 2004 Public Health Practice III: FINANCING PUBLIC HEALTH REFORM Thomas E. Novotny MD MPH University of California San Francisco Institute for.
Beyond 2015 & the SDG Framework Deirdre de Burca Beyond 2015 EU Steering Group.
Contact Monitoring Regional Network (CMKN). Why procurement It is estimated that an effective public procurement system could save as much as 25% of government.
1 Towards a Medicines Transparency Alliance (MeTA) Richard Laing and Ali Cameron with slides prepared by Michael Borowitz, DfID WHO Technical Briefing.
Medicines Transparency Alliance - Zambia Billy Mweetwa Country Medicines Advisor – Zambia.
April_2010 Partnering initiatives at country level Proposed partnering process to build a national stop tuberculosis (TB) partnership.
Medicines Transparency Alliance27/10/ MeTA Ghana Augustina Koduah (Mrs) Country Coordinator.
MeTA Medicines Transparency Alliance: Under New Management Dr Tim Reed Director, Health Action International (Global) International MeTA Secretariat.
CHAZ Public Private Partnership in PBF Public Private Partnership in PBF Church State Collaboration) Presentation to the PBF Multi-Country Conference In.
FIFTH MEETING OF HEALTH TEAM IHP+ COUNTRIES 2 – 5 December 2014, Siem Reap, Cambodia SESSION 7c) Managing Purchasing and Stock in Guinea-Bissau Current.
Objective the aim of this project was directly addressing a major health problem for Jordan by producing a guideline as a pilot in which the strengths.
META PHILIPPINES WORKPLAN : EARLY ACCOMPLISHMENTS IN THE PILOT PHASE.
Medicines systems: Convergence for access Dr Socorro Escalante WHO Country Office for Viet Nam 1.
Sida’s Support to Civil Society Presentation by Team Civil Society to Development Practioners’ Network in Prague 13 May 2009.
1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.
Policies and Procedures for Civil Society Participation in GEF Programme and Projects presented by GEF NGO Network ECW.
INTEGRATING INDIGENOUS KNOWLEDGE (IK) INTO UGANDA’S POVERTY ERADICATION ACTION PLAN (PEAP) By Joyce N. Muwanga Assistant Executive Secretary Uganda National.
Medicines Transparency Alliance Presented by Gilles Forte Department of Essential Medicines and Health Products, WHO On behalf of WHO and HAI Technical.
Background Nature and function Rationale Opportunities for TB control Partnering process.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Medicines Transparency Alliance18/12/ Country overview MeTA Kyrgyzstan Mariam Djankorozova MeTA Country coordinator.
Report of the Working Group on Tea Smallholders. Smallholders have a prominent place in tea sector. Small holders constitute 73% in Sri Lanka, 60% in.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
Wilbert Bannenberg & Elodie Brandamir Technical & Operational Directors MeTA International Secretariat MeTA Kyrgyzstan Forum Bishkek, 16 April 2009 Medicines.
Wilbert Bannenberg Technical Director, Intl MeTA Secretariat 28 April 2010, IPC meeting, Copenhagen Medicines Transparency Alliance: improving people’s.
Coordination with health service providers and local authorities Module 3 Session 3.3 National Disaster Management Practitioners, Islamabad, Pakistan.
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
MeTA Phase I: Where are we? MeTA18/06/ MeTA2 The MeTA Phase I Proposal Purpose To pilot a new multi-stakeholder approach towards increasing transparency.
Advancing Partnerships for Universal Health Coverage HANSHEP Workshop Dr. Rehana Ahmed 9 July 2015 Nairobi 1.
UHC 2030 CSO engagement mechanism Bruno Rivalan IHP+ Northern CSO Representative IHP+ Steering committee 21 th June 2016.
Engaging CSOs in UHC 2030 Bruno Rivalan IHP+ Northern CSO Representative IHP+ Steering committee 21 th June 2016.
Global Health Supply Chain Technical Assistance – Tanzania
Wilbert Bannenberg SARPAM
Implementing the guideline
Access to Medicines for HIV/AIDS, Tuberculosis and Malaria.
Guidance Session for Second Thematic Call
UHC2030 Private Sector Constituency –
National Medicines Policies
Presentation transcript:

Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22

Medicines Transparency Alliance (MeTA) Background o Roles of Sectors o Why Medicines Status of MeTA in Zambia Management Arrangements (Local) o National Secretariat o Zambia MeTA Council o MeTA Council sub-committees o MeTA Forum Way Forward

BACKGROUND MeTA is a multistakeholder alliance of partners working to improve access to medicines by increasing transparency and accountability in the healthcare marketplace The UK Department for International Development (DFID) is providing initial funding for 4 years after the pilot project ended in 2010 in 7 countries

BACKGROUND 2 Other partners include WHO, the World Bank, governments, global and national CSOs, pharmaceutical and other business interests MeTA is a multistakeholder forum representing Government, CSOs and the private sector

BACKGROUND 3 MeTA’s focus is on strengthening countries capacity to collect, analyze, disseminate and use data on medicine quality, availability, pricing and use, amongst others One of the objectives is to promote transparency and accountability in national supply chains

Roles of Sectors Public Sector plays essential role in: ◦procurement systems; have an essential role in enhancing access and reasonable costing of essential medicines ◦registration and regulation of health commodities available nationally  monitoring drug quality  public health facilities play a central role in setting national policies in regard to providing quality health delivery

Role of Sectors  Private Sector ◦Private players can influence all aspects of medicines supply and demand, that decide cost and availability of basic health commodities for end users  International and local manufacturers play an important role ◦Drug importers are likely to have an influential role in the private sector ◦Other major actors in the pharmaceutical sector include private pharmacies and other retail outlets; wholesalers of health commodities; private physicians and other medical practitioners and clinics. ◦Supply chain operators and distributors play significant roles in the safe storage, quality assurance and timely delivery of health commodities.

Role of Sectors Civil Society Organizations ◦Very broad and diverse sector which includes community, patients and consumers ◦Has a critical role in disseminating medicines information on pricing, availability, affordability etc from national to community level ◦Can represent needs of poor, socially excluded and promote social justice

WHY MEDICINES Access to essential medicines is a fundamental human right recognized by governments around the world Essential medicines are a global necessity for all countries whether rich or poor

WHY MEDICINES 2 Many people in Zambia are unable to access essential medicines to save or improve their lives Under phase two of MeTA we are including among CSOs political parties and religious organisations Many people do not have regular and affordable access to essential medicines

WHY MEDICINES 3 The importance of access to essential medicines also recognized in the Millennium Development Goals Access to ARVs has transformed AIDS into a potentially manageable chronic disease Essential medicines save lives, reduce suffering and improve health, but only if they are of good quality, safe, affordable, efficacious and used properly

Status of MeTA in Zambia Pilot ended in 2010 Phase 2 started in August 2012 but Zambia has just been funded as June 2012 Under Phase 2 MeTA Zambia will be registered. Process has started Under Pilot we covered 3 provinces – North Western, Central and Lusaka. Under phase 2 we are covering 5 provinces. We have added Copperbelt and Southern

Management Arrangements National Secretariat ◦Under pilot TIZ acted as national secretariat and fund holder ◦Under phase 2 PSZ is the fund holder ◦A Coordinator runs the Secretariat Executive Committee - The is an Executive Committee - and three subcommittees – a) Finance and Administration, b) Research and Policy c) and Communications

Management Arrangements 2 MeTA Council ◦Governing council that oversees implementation process of the workplan; makes binding decisions ◦Monitors performance of national secretariat ◦Holds bi-monthly meetings ◦Appoints executive and sub-committees ◦Develops TORs for sub-committees and rules and regulations to govern the Council ◦Current MeTA Council in existence since October 2012

Management Arrangements 3  MeTA Forum  Involves Stakeholders from a cross section of society  Main objective to discuss findings from reports on transparency and accountability concerning pricing, procurement etc. of medicines  Under phase two this will constitute the AGM where MeTA Council members will be elected/appointed  Will hold meetings annually

Way Forward Register MeTA Zambia Hold more consultations at district level about setting up district committees in five provinces Set up district committees in five provinces Hold consultations about contribution of funds to district committees from CDF Districts to identify medicineslhealth issues in their areas for advocacy